Catalent Pharma Solutions, LLC

Form 483 issued April 22, 2025 · Winchester, Kentucky

Inspection
Mar 11, 2024 – Apr 22, 2025
Observations
4
Pages
26
FEI number
1000122400

In short: On April 22, 2025, FDA issued a Form 483 with 4 observations to Catalent Pharma Solutions, LLC in Winchester, Kentucky (FEI 1000122400) after an inspection that ran Mar 11, 2024 – Apr 22, 2025. The investigators were Jeffrey T. Prosterman, Paige R. McCoy and Stephenie M. Ortiz. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.113 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Catalent Pharma Solutions, LLC?

FDA listed 4 observations on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Catalent Pharma Solutions, LLC?

Jeffrey T. Prosterman, Paige R. McCoy and Stephenie M. Ortiz are named on this Form 483, for the inspection of Mar 11, 2024 – Apr 22, 2025. Each investigator has a profile showing what they cite most.

When was Catalent Pharma Solutions, LLC inspected by FDA?

The inspection ran Mar 11, 2024 – Apr 22, 2025, and the Form 483 is dated April 22, 2025.

How do I get the full Form 483 for Catalent Pharma Solutions, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free